Andrew Wood
andrewwood.bsky.social
Andrew Wood
@andrewwood.bsky.social
Research Group Leader at the University of Edinburgh. Using genome editing and targeted protein degradation to study mechanisms underlying human disease and therapy.
Reposted by Andrew Wood
Today's a good day to remember Rosalind Franklin, British chemist and X-ray crystallographer whose untimely death meant three men shared a Nobel prize for discovering the structure of DNA for which she'd done most of the work.
November 7, 2025 at 8:02 PM
With storm Amy approaching, it’s an ideal time to get your SLiPERs on!
October 3, 2025 at 3:38 PM
Reposted by Andrew Wood
On 14th November, we are once again holding our Network Science Day in York, which is an exciting opportunity for Network members and non-members to engage and develop new collaborations!

The meeting is free to attend. Find out more and register by emailing us at [email protected].
September 16, 2025 at 12:15 PM
Our manuscript characterising tissue-specific consequences of tagged protein fusions in CRISPR-engineered mice is now online @PLOSGenetics. journals.plos.org/plosgenetics.... Thanks again to all coauthors, reviewers and editors for a smooth publication process. Brief summary below.
August 26, 2025 at 12:20 PM
New manuscript describing a modified auxin-inducible degron system ‘AID2.1’ just out in @NatComms. www.nature.com/articles/s41.... It's worth checking out the comments of Reviewer 1 in the peer review file for this one before jumping aboard...
Systematic comparison and base-editing-mediated directed protein evolution and functional screening yield superior auxin-inducible degron technology - Nature Communications
Traditional genetic perturbation tools such as siRNA and CRISPR knockout operate on timescales that render them unsuitable for exploring dynamic processes or studying essential genes, where chronic de...
www.nature.com
July 21, 2025 at 11:33 AM
Reposted by Andrew Wood
Oliver Smithies was born 100 years ago today. Best known for gene targeting in mice, for which he shared the 2007 Nobel, he also developed starch gel electrophoresis in the 1950s. I met him once and remember him being very gracious and thoughtful.
#genetics #OTD

www.nobelprize.org/prizes/medic...
Oliver Smithies – Facts - NobelPrize.orgOpen the search menuClose the search menuOpen the search menuClose the search menuSubmit a search termBack To Top
www.nobelprize.org
June 23, 2025 at 4:11 PM
Pleased to share our latest work and the first manuscript from the Degron Tagging Cluster in the MRC National Mouse Genetics Network. If you work with protein tags, particularly in tissue biology models, this should be of interest:

www.biorxiv.org/content/10.1...
www.biorxiv.org
June 19, 2025 at 8:56 PM
Reposted by Andrew Wood
New paper out in Genome Biology! 🎉
We lay out best-practice guidelines for releasing variant effect predictors, developed through the Atlas of Variant Effects Alliance @varianteffect.bsky.social

Open, interpretable, and clinically useful VEPs are the goal.

📄 doi.org/10.1186/s130...
Guidelines for releasing a variant effect predictor - Genome Biology
Computational methods for assessing the likely impacts of mutations, known as variant effect predictors (VEPs), are widely used in the assessment and interpretation of human genetic variation, as well...
doi.org
April 15, 2025 at 12:24 PM
Reposted by Andrew Wood
The first bifunctional protein degrader to deliver Phase III data! It seems to work, but people were definitely expecting more:
A Bifunctional Degrader Reads Out in Phase 3
www.science.org
March 12, 2025 at 6:53 PM
Reposted by Andrew Wood
ICYMI: Commentary on "mechanism" in dev bio

Ozpolat et al argue for diverse approaches to mechanism - from molecular to systems level

journals.biologists.com/dev/article/...
A case for broadening our view of mechanism in developmental biology
ABSTRACT. Developmental biologists can perform studies that describe a phenomenon (descriptive work) and/or explain how the phenomenon works (mechanistic work). There is a prevalent perception that mo...
journals.biologists.com
February 5, 2025 at 10:56 AM
Reposted by Andrew Wood
Every once in a while we publish a paper that moves a whole field forward. I think that's the case for this one from the Bugaj lab, where they describe proteins for THERMOGENETIC control of cellular behavior. www.nature.com/articles/s41...
A temperature-inducible protein module for control of mammalian cell fate - Nature Methods
The Melt (Membrane localization using temperature) protein translocates to the plasma membrane upon temperature shift. Melt variants with a range of switching temperatures enable straightforward therm...
www.nature.com
January 23, 2025 at 6:34 PM
Reposted by Andrew Wood
🧪 Ready, set, degrade!

So proud to share our work in the @jclinical-invest.bsky.social, establishing a versatile approach for creating transgenic dTAG mice to degrade oncoproteins. We showcase that KRAS G12V degradation triggers antitumor immunity in lung cancer.

Link: www.jci.org/articles/vie...
December 27, 2024 at 5:04 PM
Reposted by Andrew Wood
🧪1/ 🚨New paper on ecDNAs from our lab!
We reveal a strategy to engineer extrachromosomal DNA (ecDNA) amplifications in cells & mice. Let's dive in! Let’s dive in! 🧵👇
www.nature.com/articles/s41...
Engineered extrachromosomal oncogene amplifications promote tumorigenesis - Nature
Large extrachromosomal DNAs are engineered using a CRISPR- and Cre–loxP-based approach and shown to drive cancer in mouse models, with potential applications in determining the role of oncogene a...
www.nature.com
December 18, 2024 at 4:54 PM
Reposted by Andrew Wood
Americans are now one-third less likely to die from cancer at the same ages as Americans in 1990
December 9, 2024 at 10:02 AM
Reposted by Andrew Wood
Essential reading for all that serve as reviewers. Please help your authors as if they were in your lab. Make your reviews constructive.

Overly onerous reviews amount to blocking each others’ work. It slows progress and demoralizes junior investigators.

Let’s elevate, not crush, #DevBio
December 2, 2024 at 12:49 PM
Reposted by Andrew Wood
New spinout Trogenix unveils its novel treatment platform that targets aggressive cancers, including brain cancer. IRR's Professor Steven Pollard is co-founder and Chief Scientific Officer #Cancer #RegenerativeMedicine #CRM regeneration-repair.ed.ac.uk/news/irr-new...
November 19, 2024 at 4:51 PM
Reposted by Andrew Wood
Seems that @biorxivpreprint.bsky.social ought to consider adding links to @bsky.app posts given the mass transfer of scientists from Twitter to @bsky.app that is taking place.
November 18, 2024 at 1:30 AM